Our objective is to study the structure-activity relationship of corticotropins (ACTHs), lipotropins (LPHs), endorphins (EPs), melanotropins (MSHs) and related peptides. It is planned to isolate ACTH, Beta-LPH, Beta-EP and related peptides from elephant pituitary glands and to determine their amino acid sequences. Once the structure is known elephant ACTH, Beta-EP and related peptides will be synthesized by the solid-phase method. It is also planned to synthesize dogfish and amphibian ACTHs. When the synthetic peptides become available, their biological properties are investigated. Alphah-ACTH-(7-38) [corticotropin-inhibiting peptide (CIP)], the naturally occurring inhibitor to ACTH, is a weak antagonist. It is hope to synthesize analogs of CIP with higher inhibitory activity. Similarly, it is planned to synthesize analogs of Betah-EP-(1-27), [Beta-EP inhibiting peptide (BetaEIP)], the naturally occurring inhibitor to Beta-EP-induced analgesia, with higher inhibitory activity. For the development of sensitive and specific radioimmunoassays (RIAs) for rat and human Gamma-LPH, it is necessary to synthesize these two Gamma-LPHs by the solid-phase method. ACTH and related peptides are known to exhibit no three dimentional structures in water. It is planned to investigate the presence of a tertiary structure in aqueous solutions of human ACTH, Beta-MSH and Alpha-MSH by difference absorption spectroscopy of enzymic digests of the hormones.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
2R01GM002907-36
Application #
3267845
Study Section
Biochemical Endocrinology Study Section (BCE)
Project Start
1977-03-01
Project End
1992-02-29
Budget Start
1987-03-01
Budget End
1988-02-29
Support Year
36
Fiscal Year
1987
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Ruthstein, Sharon; Ji, Ming; Mehta, Preeti et al. (2013) Sensitive Cu2+-Cu2+ distance measurements in a protein-DNA complex by double-quantum coherence ESR. J Phys Chem B 117:6227-30
Cuthbert, B N; Holaday, J W; Meyerhoff, J et al. (1989) Intravenous beta-endorphin: behavioral and physiological effects in conscious monkeys. Peptides 10:729-34
Triscari, J; Nelson, D; Vincent, G P et al. (1989) Effect of centrally and peripherally administered beta-endorphin on food intake in rats. Int J Pept Protein Res 34:358-62
Ramasharma, K; Yamashiro, D; Li, C H (1988) Human follicular gonadotropin releasing peptide analogs. Evaluation of biological (in vitro) and immunological activity. Int J Pept Protein Res 32:419-24
Ho, C L; Ko, J L; Li, C H (1988) Beta-endorphin. Receptor binding and peripheral opioid activities of [Gln8]-, [Trp27]-, and [Tyr31]-analogs. Int J Pept Protein Res 32:74-8
Yu, W H; McCann, S M; Li, C H (1988) Synthetic human seminal alpha-inhibin-92 selectively suppresses follicle-stimulating hormone release in vivo. Proc Natl Acad Sci U S A 85:289-92
Li, C H; Oosthuizen, M M; Chung, D (1988) Isolation and primary structures of elephant adrenocorticotropin and beta-lipotropin. Int J Pept Protein Res 32:573-8
Yamashiro, D; Li, C H (1988) New segment synthesis of alpha-inhibin-92 by the acyl disulfide method. Int J Pept Protein Res 31:322-34
Suh, H H; Tseng, L F; Li, C H (1987) Beta-endorphin-(1-27) antagonizes beta-endorphin-induced hypothermia in mice. Peptides 8:123-6
Yamashiro, D; Li, C H (1987) Solid-phase synthesis of insulin-like growth factor I. Methods Enzymol 146:199-207

Showing the most recent 10 out of 48 publications